Skip to main content
. 2014 Feb 11;35(6):1284–1291. doi: 10.1093/carcin/bgu034

Fig. 1.

Fig. 1.

Kaplan–Meier estimates of recurrence-free survival stratified by treatment for early-stage NSCLC patients grouped by the number of unfavorable genotypes in the predictive markers for surgery-only (A and B) and predictive markers for surgery plus chemotherapy (C and D). UFG: number of unfavorable genotypes as depicted in Table IV.